Ophthalmology

Top Story

Agreement seen between ultra-widefield, ETDRS images for grading diabetic retinopathy severity

November 13, 2018

Second Sight posts quarterly net loss

November 13, 2018
Second Sight Medical Products reported a net loss of $8.5 million, or $0.12 per share, in the third quarter of 2018 compared with a net loss of $6.7 million, or $0.12…

Zimura-Lucentis combination safe in wet AMD patients in phase 2a trial

November 13, 2018
Zimura, a complement factor C5 inhibitor, was found to be well tolerated in combination with Lucentis in a phase 2a clinical trial, Ophthotech announced in a press…

Quarterly loss decreases for ProQR

November 13, 2018
ProQR Therapeutics reported a net loss of 6 million euros, or 0.18 euros per share, in the third quarter of 2018 compared with a net loss of 10.5 million euros, or 0.42…

Santen launches Verkazia in Europe to treat VKC in children

November 13, 2018
Santen U.K. Ltd. announced the launch of Verkazia eye drops in Europe for the treatment of severe vernal keratoconjunctivitis in adolescents and children at least 4…
More Headlines »
Experimental Science

Effects of Brimonidine on Retinal Pigment Epithelial Cells and Müller Cells Exposed to Amyloid-Beta 1–42 Peptide In Vitro

Ophthalmic Surgery, Lasers and Imaging Retina, October 2018, Volume 49 Issue 10
To evaluate whether brimonidine can prevent cytotoxicity in human retinal pigment epithelial (RPE) and Müller (MIO)…
More »
CME

Ocular Surface Disease: Pearls on Diagnosis and Treatment

This activity is supported by an educational grant from Shire.

Ocular surface disease (OSD) encompasses several disorders, including dry eye disease, blepharitis, meibomian gland…
More »
Resource Centers
American Academy of Ophthalmology Meeting

American Academy of Ophthalmology Meeting

Video
Meeting News

VIDEO: Glaucoma space treatment options advancing

November 7, 2018
More »